AMBS

Amarantus Bioscience Holdings, Inc.

 
Common Stock SEC Reporting - Delinquent
OTC Pink Limited Information
Verified Company Profile 9/28/2016
Contact Info
  • 655 Montgomery Street
  • Suite 900
  • San Francisco, CA 94111

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2016 10-Q
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2008
Employees 10 a/o Mar 08, 2016
Company Officers/Contacts
Gerald E. Commissiong CEO, President, COO
Company Directors
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
Donald D. Huffman
Joseph Rubinfeld
Company Notes
  • Formerly=Amarantus Bioscience, Inc. until 4-2013
  • Formerly=Amarantus Biosciences, Inc. until 12-2012
  • Formerly=Jumpkicks, Inc. until 6-2011
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sheppard, Mullin, Richter & Hampton LLP
Four Embarcadero Center, 17th Floor
San Francisco, CA, 94111
United States

Investor Relations Firm
Not Available
AMBS Security Details
Share Structure
Market Value1 $2,149,394 a/o Dec 09, 2016
Authorized Shares 150,000,000 a/o Nov 30, 2016
Outstanding Shares 78,790,093 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 67,000,000 a/o Jun 01, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 68 a/o Jun 01, 2016
Short Selling Data
Short Interest 100 (-99.56%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security